Lixia Xu

865 total citations
35 papers, 586 citations indexed

About

Lixia Xu is a scholar working on Nephrology, Cardiology and Cardiovascular Medicine and Molecular Biology. According to data from OpenAlex, Lixia Xu has authored 35 papers receiving a total of 586 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Nephrology, 7 papers in Cardiology and Cardiovascular Medicine and 6 papers in Molecular Biology. Recurrent topics in Lixia Xu's work include Renal Diseases and Glomerulopathies (6 papers), Cancer-related molecular mechanisms research (3 papers) and Acute Kidney Injury Research (3 papers). Lixia Xu is often cited by papers focused on Renal Diseases and Glomerulopathies (6 papers), Cancer-related molecular mechanisms research (3 papers) and Acute Kidney Injury Research (3 papers). Lixia Xu collaborates with scholars based in China, United States and Taiwan. Lixia Xu's co-authors include Shuangxin Liu, Xinling Liang, Wenjian Wang, Da Wang, Shen Tian, Guang‐Hui Dong, Miao Liu, Qiao Lin, Ruizhao Li and Zhilian Li and has published in prestigious journals such as Nature Communications, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Lixia Xu

33 papers receiving 570 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Lixia Xu China 13 172 121 98 95 54 35 586
Ghada N. Farhat United States 16 165 1.0× 122 1.0× 68 0.7× 172 1.8× 149 2.8× 26 1.0k
Elizabeth Li United States 11 62 0.4× 167 1.4× 176 1.8× 117 1.2× 22 0.4× 51 534
V.S. Balakrishnan United States 14 59 0.3× 142 1.2× 251 2.6× 71 0.7× 36 0.7× 26 848
Nigel Baker United Kingdom 13 145 0.8× 250 2.1× 251 2.6× 173 1.8× 24 0.4× 24 1.2k
Patricia Sorroche Argentina 16 53 0.3× 101 0.8× 56 0.6× 68 0.7× 45 0.8× 58 626
Yongjiang Tang China 11 83 0.5× 118 1.0× 74 0.8× 146 1.5× 15 0.3× 32 494
Kazunori Murata United States 15 59 0.3× 141 1.2× 152 1.6× 75 0.8× 67 1.2× 31 828
Takahiro Kuragano Japan 21 49 0.3× 83 0.7× 445 4.5× 101 1.1× 15 0.3× 62 1.2k
Purna Mukhopadhyay United States 12 163 0.9× 96 0.8× 141 1.4× 136 1.4× 31 0.6× 27 679
Mika Matsumoto Japan 15 245 1.4× 66 0.5× 88 0.9× 76 0.8× 11 0.2× 54 685

Countries citing papers authored by Lixia Xu

Since Specialization
Citations

This map shows the geographic impact of Lixia Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lixia Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lixia Xu more than expected).

Fields of papers citing papers by Lixia Xu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lixia Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lixia Xu. The network helps show where Lixia Xu may publish in the future.

Co-authorship network of co-authors of Lixia Xu

This figure shows the co-authorship network connecting the top 25 collaborators of Lixia Xu. A scholar is included among the top collaborators of Lixia Xu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lixia Xu. Lixia Xu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
3.
Xu, Lixia, et al.. (2025). LncRNA CYP1B1-AS1 as a clinical biomarker exacerbates sepsis inflammatory response via targeting miR- 18a- 5p. BMC Immunology. 26(1). 32–32. 2 indexed citations
4.
Hu, Tingting, Lixia Xu, Weijia Fan, et al.. (2025). Fingolimod Suppresses NLRP3 Inflammasome Activation and Alleviates Oxidative Stress in Traumatic Brain Injury-Induced Acute Lung Injury. Journal of Inflammation Research. Volume 18. 2229–2245. 1 indexed citations
5.
Wang, Xiaoxia, et al.. (2024). Genomic characterization of Pantoea dispersa A003 isolated from a clinical patient. SHILAP Revista de lepidopterología. 3. 1 indexed citations
6.
Liu, Rui, et al.. (2024). Therapeutic effects of ginsenosides on osteoporosis for novel drug applications. European Journal of Pharmacology. 974. 176604–176604. 5 indexed citations
7.
Zhou, Yan, et al.. (2023). Temozolomide-based sonodynamic therapy induces immunogenic cell death in glioma. Clinical Immunology. 256. 109772–109772. 29 indexed citations
8.
Zhang, Fan, et al.. (2023). Effects of peripheral blood neutrophil/lymphocyte ratio levels and their changes on the prognosis of patients with early cervical cancer. Frontiers in Oncology. 13. 1139809–1139809. 3 indexed citations
9.
Xu, Lixia, Ruixing Wang, G. F. Yi, et al.. (2023). TRPC6 promotes daunorubicin-induced mitochondrial fission and cell death in rat cardiomyocytes with the involvement of ERK1/2-DRP1 activation. Toxicology and Applied Pharmacology. 470. 116547–116547. 7 indexed citations
10.
Xu, Lixia, Yan Zhou, Haiyang Wu, et al.. (2022). Ultrasound-excited temozolomide sonosensitization induces necroptosis in glioblastoma. Cancer Letters. 554. 216033–216033. 24 indexed citations
12.
Wang, Xipei, Hongbo Gao, Zhonglin Feng, et al.. (2020). Effect of Hemodialysis on Efficacy and Pharmacokinetics of Sofosbuvir Coformulated with Either Daclatasvir or Ledipasvir in Patients with End-Stage Renal Disease. Blood Purification. 49(6). 692–699. 3 indexed citations
13.
Calandrelli, Riccardo, Lixia Xu, Yingjun Luo, et al.. (2020). Stress-induced RNA–chromatin interactions promote endothelial dysfunction. Nature Communications. 11(1). 5211–5211. 40 indexed citations
14.
Xu, Lixia, Rama Natarajan, & Zhen Chen. (2019). Epigenetic Risk Profile of Diabetic Kidney Disease in High-Risk Populations. Current Diabetes Reports. 19(3). 9–9. 12 indexed citations
15.
Xu, Qi, et al.. (2015). A Literature Review on Supply Chain Contracts Selection and Coordination under Competing Multi Manufacturers. International Journal of Business and Management. 10(7). 6 indexed citations
16.
Xu, Lixia, et al.. (2014). Wal-Mart and Carrefour’s Supply Chain Management Strategies in China. International Journal of Business and Management. 9(7). 7 indexed citations
17.
Li, Zhilian, Xinling Liang, Shuangxin Liu, et al.. (2014). Pulmonary Hypertension: Epidemiology in Different CKD Stages and Its Association with Cardiovascular Morbidity. PLoS ONE. 9(12). e114392–e114392. 31 indexed citations
18.
Ma, Jianchao, Bin Zhang, Shuangxin Liu, et al.. (2013). 1,25-Dihydroxyvitamin D(3) Inhibits Podocyte uPAR Expression and Reduces Proteinuria. PLoS ONE. 8(5). e64912–e64912. 16 indexed citations
19.
Li, Zhilian, Shuangxin Liu, Xinling Liang, et al.. (2013). Pulmonary hypertension as an independent predictor of cardiovascular mortality and events in hemodialysis patients. International Urology and Nephrology. 46(1). 141–149. 31 indexed citations
20.
Liu, Shuangxin, Wei Shi, Xinling Liang, et al.. (2012). Receptor Activator of NF-kappaB and Podocytes: Towards a Function of a Novel Receptor-Ligand Pair in the Survival Response of Podocyte Injury. PLoS ONE. 7(7). e41331–e41331. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026